Léger, J., De Bleecker, J. L., Sommer, C., Robberecht, W., Saarela, M., Kamienowski, J., . . . Merkies, I. S. J. (2013). Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: Results of a prospective, single-arm, open-label Phase III study (the PRIMA study). Wiley Periodicals, Inc.
Chicago-tyylinen lähdeviittausLéger, Jean-Marc, et al. Efficacy and Safety of Privigen® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-arm, Open-label Phase III Study (the PRIMA Study). Wiley Periodicals, Inc, 2013.
MLA-viiteLéger, Jean-Marc, et al. Efficacy and Safety of Privigen® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-arm, Open-label Phase III Study (the PRIMA Study). Wiley Periodicals, Inc, 2013.